Sanquin Selects Abbott’s "Alinity s" Solution for Blood and Plasma Screening
Long-term agreement helps ensure a safe and efficient blood supply in the Netherlands
Long-term agreement helps ensure a safe and efficient blood supply in the Netherlands
The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics
SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism
NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research
Experts discuss the expanding role of mass spectrometry in forensic toxicology and drug monitoring research
Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers
From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
An optimized, automated workflow enables continued growth of the clinical mass spectrometry service at this leading London Trust
Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute
The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing
Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease
Read exclusive interviews from experts in healthcare settings around the world, to discover how mass spectrometry is improving clinical diagnostics
Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research
New test to identify IBS sufferers who respond to diet restrictions